Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Atrium Therapeutics, Inc.NASDAQ: RNA

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses of $36.76M in Q1 FY2026

Q1 FY2026 operating expenses was $36.76M.

Context

  • Operating expenses amounted to 512.6% of revenue in FY2025.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$36.76M-24.8% QoQ
Last fiscal yearDec 2025
$95.43M— YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
95.43M USD
Year-over-year change
—

Operating Expenses vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Operating Expenses figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.